Moreover, our data provide a starting point for further investigations to assess the relationships between THOR methylation status, hTERT expression, and TF binding with THOR in order to fully understand the sophisticated molecular mechanism of hTERT activation in CTCL. The gene discussed is THORLNC; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.